Predictive Factors for Ipsilateral Recurrence After Nephron-sparing Surgery in Renal Cell Carcinoma

European Urology

Volumn 57, Issue 6, 2010, Pages 1080-1086

  Bernhard, Jean Christophe ^a   Pantuck, Allan J ^b   Wallerand, Hervé ^a   Crepel, Maxime ^c   Ferrière, Jean Marie ^a   Bellec, Laurent ^d   Maurice Tison, Sylvie ^a   Robert, Grégoire ^a   Albouy, Baptiste ^e   Pasticier, Gilles ^a   Soulie, Michel ^d   Lopes, David ^f   Lacroix, Bertrand ^g   Bensalah, Karim ^c   Pfister, Christian ^e   Thuret, Rodolphe ^h   Tostain, Jacques ^g   De La Taille, Alexandre ^f   Salomon, Laurent ^f   Abbou, Clément ^f   Colombel, Marc ⁱ   Belldegrun, Arie S ^b   Patard, Jean Jacques ^c   more..

^a University Hospital   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f University Hospital   (France)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ University Hospital   (France)

Author keywords

Local recurrence; Nephrectomy; Prognosis; Renal cell carcinoma; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TREATMENT INDICATION; UNIVARIATE ANALYSIS;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR BURDEN;

EID: 77951623525     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.02.019     Document Type: Article

References (30)

1. Home (European Cancer Observatory). International Agency for Research on Cancer Web site. http://eu-cancer.iarc.fr. Updated March 16, 2009. Accessed December 13, 2009.
2. Hock L.M., Lynch J., and Balaji K.C. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167 (2002) 57-60
3. Bazeed M.A., Schärfe T., Becht E., Jurincic C., Alken P., and Thüroff J.W. Conservative surgery of renal cell carcinoma. Eur Urol 12 (1986) 238-243
4. Lerner S.E., Hawkins C.A., Blute M.L., et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 155 (1996) 1868-1873
5. Belldegrun A., Tsui K.H., deKernion J.B., and Smith R.B. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumour-node-metastasis staging system. J Clin Oncol 17 (1999) 2868-2875
6. Hafez K.S., Fergany A.F., and Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumour size on patient survival, tumour recurrence and TNM staging. J Urol 162 (1999) 1930-1933
7. Bensalah K., Crépel M., and Patard J.-J. Tumor size and nephron-sparing surgery: does it still matter?. Eur Urol 53 (2008) 691-693
8. Patard J.-J., Pantuck A.J., Crepel M., et al. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 52 (2007) 148-154
9. Novick A.C., Streem S., Montie J.E., et al. Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol 141 (1989) 835-839
10. Lapini A., Serni S., Minervini A., Masieri L., and Carini M. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients. J Urol 174 (2005) 57-60 discussion 60
11. Martorana G., Lupo S., Brunocilla E., Concetti S., Malizia M., and Vece E. Role of nephron sparing surgery in the treatment of centrally located renal tumours. Arch Ital Urol Androl 76 (2004) 51-55
12. Yossepowitch O., Thompson R.H., Leibovich B.C., et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179 (2008) 2158-2163
13. In: Sobin L., and Wittekind C. (Eds). TNM classification of malignant tumours. ed. 6. (2002), Wiley-Liss, New York, NY
14. Lopez-Beltran A., Scarpelli M., Montironi R., and Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 49 (2006) 798-805
15. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655-663
16. Leibovich B.C., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171 (2004) 1066-1070
17. Patard J.J., Shvarts O., Lam J.S., et al. Safety and efficacy of partial nephrectomy for all T1 tumours based on an international multicenter experience. J Urol 171 (2004) 2181-2185 quiz 2435
18. Mitchell R.E., Gilbert S.M., Murphy A.M., Olsson C.A., Benson M.C., and McKiernan J.M. Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumours 4 cm or larger. Urology 67 (2006) 260-264
19. Karakiewicz P.I., Lewinshtein D.J., Chun F.K.-H., et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 50 (2006) 521-529 discussion 529
20. Thompson R.H., Boorjian S.A., Lohse C.M., et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179 (2008) 468-471 discussion 472-3
21. Ljungberg B., Hanbury D.C., Kuczyk M.A., et al. Renal cell carcinoma guideline. Eur Urol 51 (2007) 1502-1510
22. Pahernik S., Cudovic D., Roos F., Melchior S.W., and Thuroff J.W. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes. BJU Int 100 (2007) 26-29
23. Blute M.L., Itano N.B., Cheville J.C., Weaver A.L., Lohse C.M., and Zincke H. The effect of bilaterality, pathological features and surgical outcome in non hereditary renal cell carcinoma. J Urol 169 (2003) 1276-1281
24. Blute M.L., Thibault G.P., Leibovich B.C., Cheville J.C., Lohse C.M., and Zincke H. Multiple ipsilateral renal tumours discovered at planned nephron sparing surgery: importance of tumour histology and risk of metachronous recurrence. J Urol 170 (2003) 760-763
25. Klatte T., Patard J.J., Wunderlich H., et al. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol 177 (2007) 2081-2086 discussion 2086-7
26. Gohji K., Hara I., Gotoh A., et al. Multifocal renal cell carcinoma in Japanese patients with tumours with maximal diameters of 50 mm or less. J Urol 159 (1998) 1144-1147
27. Klatte T., Wunderlich H., Patard J.J., et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int 100 (2007) 21-25
28. Sutherland S.E., Resnick M.I., Maclennan G.T., and Goldman H.B. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter?. J Urol 167 (2002) 61-64
29. Kwon E.O., Carver B.S., Snyder M.E., and Russo P. Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int 99 (2007) 286-289
30. Bensalah K., Pantuck A.J., Rioux-Leclercq N., et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 57 (2010) 466-473